CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
AI Description
This trial evaluates the effectiveness of CardioHeartConnect, an eight-week mobile cardiac rehabilitation intervention using Peloton fitness modules, compared to educational control among patients recovering from transcatheter aortic valve replacement (TAVR). The study aims to improve physical activity, functional capacity, quality of life, and cardiovascular health using wearable devices and a digital engagement platform. A total of 200 patients will be recruited from the UCHealth Structural Heart and Valve Clinic and randomized to either CardioHeartConnect or CardioHeartEd. Participants will be assessed at baseline, 8 weeks, and 12 months using surveys, smartwatch data, and electronic health records.
- Who can join
- adult, older adult
- Participants
- 200
- Expected completion
- 2029-08-01
- Funded by
- other
Conditions studied
Aortic Valve Disease, Aortic Valve Stenosis
What is being tested
- BEHAVIORAL: CardioHeartConnect
- BEHAVIORAL: CardioHeartEd
What it measures
- Change in physical activity measured by average daily steps, Change in mean daily steps from baseline to 8 weeks, measured using smartwatch accelerometer data collected through the Ortus platform. Steps will serve as the primary endpoint to evaluate the effect of CardioHeartConnect compared with control., Baseline to 8 weeks (Primary); 8 weeks, and 12 months (Secondary)
Working with
National Heart, Lung, and Blood Institute (NHLBI)
Centers Participating
These centers are participating in this study. Reach out to them directly to learn more.
Registry entry updated 2026-08-03
Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.
If you would rather we did it with you, call us on (656) 206-4686.